
Pathways to Care: Updates on CSU
This educational infographic program for allergists and dermatologists delves into the inflammatory pathway of chronic spontaneous urticaria (CSU) and identifies potential treatment targets related to its pathophysiology. The program describes biomarkers suggesting CSU endotypes, highlighting their characteristics and potential use in management decisions. The program also summarizes evidence for the efficacy and safety of current and emerging agents for CSU treatment beyond first-line therapy, providing clinicians with the latest insights to enhance patient care and treatment outcomes.
This activity is provided in partnership with Paradigm Medical Communications, LLC.
Pathways to Care: Updates on CSU is funded through an educational grant from Genentech, a member of the Roche Group.
Target Audience
This activity has been designed to meet the educational needs of allergists, dermatologists, and dermatology and allergy nurse practitioners and PAs. It may also benefit primary care physicians, nurse practitioners, and PAs, and other clinicians who are interested in the management of patients with chronic urticaria.
Learning Objectives
Upon completion of this course, learners will be able to:
- Describe the current understanding of the inflammatory pathway of CSU and potential treatment targets
- Interpret biomarkers suggesting endotypes of CSU and their characteristics, and potential use in management decisions
- Summarize evidence for the efficacy and safety of emerging agents for the treatment of CSU beyond first-line therapy
The information disclosed by the speakers, planning committee, and reviewers was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Faculty
David M. Lang, MD
Relevant Relationships: Bluepoint; Genentech, Inc; Novartis AG (advisory board); Astra Zeneca; Celldex Therapeutics; Novartis AG (consultant); Sanofi-Regeneron (speaker)
Content Reviewer
Shirly Joo, MD
Relevant Relationships: None
Staff
AAAAI and Paradigm Medical Communication, LLC staff have no relevant financial relationships in relation to this activity.
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
• Employment. Name of employer and job title.
• Financial interests. All organizations, other than the employer, from which the faculty member receives annual remuneration in any amount (including grants, honoraria and consulting fees).
• Research interests. All organizations which support research projects for which the faculty member serves as an investigator.
• Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
• Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
• Gifts. All organizations from which the faculty member have received a gift of any amount in the last year.
• Other interests. All interests of the faculty member that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 0.5 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Individuals are responsible for checking with the NCCPA and completing the necessary steps for accreditation.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on July 31, 2026. Requests to claim credit on or after August 1, 2026 will be denied.
Medium and Method of Physician Participation
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME and Disclosure information.
- Complete all required components.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
Questions
Activity-related questions should be directed to [email protected]
Available Credit
- 0.50 AttendanceAttendance credit.
- 0.50 CMECME credit.
Price
By registering for this educational activity you are confirming that you have read the Privacy and Data Protection Notice and agree to the terms as outlined below:
Privacy and Data Protection Notice
The American Academy of Allergy, Asthma & Immunology (AAAAI) takes your privacy seriously. AAAAI will only use your personal information to administer your registration, attendance, and credit claiming/attendance record for this activity, to provide services that you have requested from AAAAI and otherwise as you may expressly consent. A complete copy of AAAAI’s Legal and Privacy Notices, the terms of which are incorporated herein, can be found here.
By providing consent, you are allowing AAAAI to process your personal data. AAAAI will collect and store information you provide in the Registration/Housing Forms for the purposes of enabling us to register your attendance at the activity; to assist with administrative, planning and marketing purposes; and to allow the compilation and analysis of statistics relevant to AAAAI.
The information you provide in the Registration/Housing Forms, and information provided at any other time during this activity, including without limitation any feedback obtained during the activity, will be used by AAAAI to offer, provide and continue to improve its educational activities and other services. The AAAAI will also use your email address to communicate important information regarding this activity and for marketing purposes for future activities. AAAAI will not otherwise, without your consent, use or disclose your personal information for any purpose unless it would reasonably be expected that such a purpose is related to the offer, provision and improvement of the activity or where such purpose is permitted or required by law.
For courses/events with industry support and/or exhibitors, The AAAAI may disclose some information that is collected in the Registration Form such as your name, credentials, title/position, organization, and mailing address to exhibitors and industry supporters for marketing purposes such as to receive mailed literature. In addition to, but separate from, your consent regarding being contacted by exhibitors and industry supporters with mailed literature, when you visit sponsored areas within the virtual platform for an online event (such as, but not limited to, an exhibitor’s virtual exhibit booth), that organization will receive your personal contact information (name, credentials, title/position, organization, mailing address, phone number, email address and NPI number, if applicable). If you do not want to share your personal contact information with any/all of those organizations, please do not visit those areas within our virtual platform. By accessing any/all of those areas in our virtual platform, you are consenting to share your personal contact information with all organizations whose sponsored areas you visit in our virtual platform. If you attend this activity in person, and provide your contact information to an exhibitor or industry supporter (including allowing them to scan your name badge), you are consenting to share your personal contact information with that organization. You have the right to decline an exhibitor and/or industry supporter’s request for your personal contact information. AAAAI does not control the use or distribution of personal contact information transferred when you visit a sponsored area in the virtual platform or, if in person, when you share your personal contact information, and as such, AAAAI shall not be held responsible for any misuse of your personal data obtained by exhibitors or industry supporters in this manner. You have the right to ask the exhibitor or industry supporter questions about how they will use your personal data, how long it will be retained and if they will share information with third parties.
After you have submitted your personal contact information in the registration form, you may change your preferences for receiving emails by following the instructions below:
· To change your preferences for receiving emails from AAAAI regarding future annual meetings and/or other in-person and online education programs, please visit http://aaaai.execinc.com/edibo/Profile
· For events where industry support or exhibitions are involved please email [email protected] to change your consent to be contacted by the industry supporters and exhibitors of that activity.
I understand that it is my right to withhold consent to the above Privacy and Data Protection Notice, or to withdraw my previous consent at any time. I further understand that without my consent, it is not possible to process my registration/housing request for this activity. Please contact the AAAAI Education Team at (414) 272-6071 if you have any further questions about how this will affect your registration/housing request for this activity.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari. Internet Explorer is no longer supported.
Pop-ups must be enabled in order to access all course content. The course will pop up in a new window. When you finish the content, you must close the pop-up in order to move forward.

Facebook
X
LinkedIn
Forward